Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 202 of 1,261

  1. AU 2021323364

    Antimicrobial peptidomimetics

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Mar 30, 2023 · Expires Mar 25, 2043

    granted

  2. AR 124446

    POLIPÉPTIDOS RECLUTADORES DE CÉLULAS T BASADOS EN LA REACTIVIDAD DE TCR a / b

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted

  3. AR 124425

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES SIMPLES DE INMUNOGLOBULINA DIRIGIDOS A GLYPICAN-3 Y AL RECEPTOR DE CÉLULAS T

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted

  4. AR 124426

    POLIPÉPTIDOS QUE COMPRENDEN DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA QUE SE DIRIGEN A IL-6 Y TNF-a

    ABLYNX NV [BE] · Granted Mar 29, 2023 · Expires Mar 24, 2043

    granted

  5. US 11612652

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  6. US 11613538

    Method of inhibiting or reducing a viral infection

    PTC THERAPEUTICS, INC. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  7. US 11613744

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  8. US 11613750

    Methods of reducing virus molecule levels

    Aligos Therapeutics, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  9. US 11613752

    Compositions and methods for modulating PKK expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  10. US 11613764

    T cell receptors that bind to NY-ESO-1 and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  11. US 11613560

    Bicyclic peptide ligands specific for OX40

    BicycleTx Limited · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  12. US 11613586

    Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

    Takeda Pharmaceutical Company Limited · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  13. US 11613544

    Substituted imidazo[1,5-a]pyrazines for modulation of IRE1

    The Regents of the University of California · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  14. US 11613559

    Nucleic acid construct

    AUTOLUS LIMITED · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  15. US 11612575

    Combination therapies with disulfiram

    Spring Discovery, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  16. US 11613758

    Engineered bacteria for production and release of therapeutics

    The Regents of the University of California · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  17. US 11613754

    Toxic RNAi active seed sequences for killing cancer cells

    Northwestern University · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  18. US 11612657

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  19. US 11612580

    Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions

    The Board of Regents of the University of Texas System · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  20. US 11613511

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  21. US 11613735

    Methods for reprograming non-hepatocyte cells into hepatocyte cells

    BeiHao Stem Cell and Regenerative Medicine Translational Research Institute · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  22. US 11613527

    Enzyme inhibitors

    KalVista Pharmaceuticals Limited · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  23. US 11613528

    Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  24. US 11612663

    Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

    The Regents of the University of California · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.